» Authors » Cassandre Von Platen

Cassandre Von Platen

Explore the profile of Cassandre Von Platen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 290
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Perrey C, Mailles A, Septfons A, Charmet T, Cheny O, Von Platen C, et al.
Infect Dis Now . 2024 Jun; 54(6):104943. PMID: 38936477
Objectives: This study aims to understand a major result of ComCor, an online epidemiological study conducted to identify the circumstances of COVID-19 infection in France from 2020 to 2022: One...
2.
Galmiche S, Charmet T, Rakover A, Schaeffer L, Cheny O, Von Platen C, et al.
JAMA Netw Open . 2023 Sep; 6(9):e2334084. PMID: 37713194
Importance: Understanding the contribution of children to SARS-CoV-2 circulation in households is critical for designing public health policies and mitigation strategies. Objective: To identify temporal changes in the risk of...
3.
Galmiche S, Cortier T, Charmet T, Schaeffer L, Cheny O, Von Platen C, et al.
Lancet Microbe . 2023 Apr; 4(6):e409-e417. PMID: 37084751
Background: The incubation period of SARS-CoV-2 has been estimated for the known variants of concern. However, differences in study designs and settings make comparing variants difficult. We aimed to estimate...
4.
Besombes C, Mbrenga F, Schaeffer L, Malaka C, Gonofio E, Landier J, et al.
Emerg Infect Dis . 2022 Nov; 28(12):2435-2445. PMID: 36328951
We analyzed monkeypox disease surveillance in Central African Republic (CAR) during 2001-2021. Surveillance data show 95 suspected outbreaks, 40 of which were confirmed as monkeypox, comprising 99 confirmed and 61...
5.
Grant R, Charmet T, Schaeffer L, Galmiche S, Madec Y, Von Platen C, et al.
Lancet Reg Health Eur . 2021 Dec; 13:100278. PMID: 34849500
Background: We aimed to assess the settings and activities associated with SARS-CoV-2 infection in the context of B.1.617.2 (Delta) variant circulation in France, as well as the protection against symptomatic...
6.
Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, et al.
J Infect Dis . 2021 Jul; 224(9):1489-1499. PMID: 34282461
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a complex antibody response that varies by orders of magnitude between individuals and over time. Methods: We developed a...
7.
Charmet T, Schaeffer L, Grant R, Galmiche S, Cheny O, Von Platen C, et al.
Lancet Reg Health Eur . 2021 Jul; 8:100171. PMID: 34278372
Background: We aimed to assess the effectiveness of two doses of mRNA COVID-19 vaccines against COVID-19 with the original virus and other lineages circulating in France. Methods: In this nationwide...
8.
Tall H, Adam P, Tiendrebeogo A, Vincent J, Schaeffer L, Von Platen C, et al.
Vaccines (Basel) . 2021 Jul; 9(6). PMID: 34206058
To achieve global hepatitis elimination by 2030, it is critical to prevent the mother-to-child transmission (MTCT) of hepatitis B virus (HBV). Since 2009, the WHO has recommended administering hepatitis B...
9.
Galmiche S, Charmet T, Schaeffer L, Paireau J, Grant R, Cheny O, et al.
Lancet Reg Health Eur . 2021 Jun; 7:100148. PMID: 34124709
Background: We aimed to assess the role of different setting and activities in acquiring SARS-CoV-2 infection. Methods: In this nationwide case-control study, cases were SARS-CoV-2 infected adults recruited between 27...
10.
Rabenandrasana M, Rafetrarivony L, Rivoarilala L, Enouf V, Robinson A, Rakotozanany A, et al.
Microbiol Resour Announc . 2019 Aug; 8(35). PMID: 31467100
We report here the draft genome sequence of a strain, isolated from a blood culture of a 2.2-year-old child admitted to the hospital for vomiting and coughing. The genome was...